X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

INZY

Closed

Inozyme Pharma inc

4.
0 (0.00%)
Last Update: 30 Jun 2025 23:19:00
Yesterday: 3.99
Day's Range: 3.99 - 4.
Send
When Written:
 
5.42
Inozyme Pharma Inc is a biopharmaceutical company focused on developing novel therapies for the treatment of rare diseases related to abnormal mineralization. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts.

Inozyme's lead product candidate, INZ-701, is an enzyme replacement therapy designed to treat a rare genetic disorder called hypophosphatasia (HPP), which causes abnormal mineralization of bones and teeth. The company is also developing other product candidates for the treatment of rare diseases related to abnormal mineralization.

Inozyme is led by a team of experienced biopharmaceutical executives and has collaborations with academic institutions and pharmaceutical companies. The company went public in August 2020 and is listed on the NASDAQ under the ticker symbol "INZY".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X